Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)

Columbia University Medical Center, New York

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

Rare Disease Research, Hillsborough

UNC Chapel Hill Pediatrics, Chapel Hill

Hospital Universitario Puerta de Hierro, Madrid

Rare Disease Research, Atlanta

Nicklaus Children's Hospital, Miami

Hospital Universitario Virgen del Rocio, Seville

Rush University, Chicago

Children's Mercy, Kansas City

Carum Research Inc, Dallas

The University of Texas, Austin

Children's Hospital Colorado, Aurora

Medical University of Gdańsk, Gdansk

Haunersche Kinderklinik, Munich

Cedars Sinai, Los Angeles

UCSD, Rady Children's Hospital, San Diego

UCSF, San Francisco

Boston Children's Hospital, Boston

McGill University Health Centre, Montreal

British Columbia Children's Hospital, Vancouver

University of Leipzig, Leipzig

Nagoya City University Graduate School of Medical Sciences, Nagoya

Osaka City General Hospital, Osaka

Hokkaido University Hospital, Sapporo

Polish Mothers Memorial Institute, Lodz

Hospital Universitario Parc Tauli, Barcelona

Hospital Sant Joan de Deu, Barcelona